Genomic Characterization of Selected ESKAPEEE Clinical Isolates From Mbarara Regional Referral Hospital, Southwestern Uganda: Resistome, Multilocus Sequence Typing, Mobilome, and Virulome.

Judith Owokuhaisa, Joel Bazira, Moses Mpeirwe, Godwin Tusabe, Edgar Mulogo

Abstract read

In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Judith OwokuhaisaDepartment of Microbiology, Mbarara University of Science and Technology, Mbarara, UGA.

Joel BaziraDepartment of Microbiology, Mbarara University of Science and Technology, Mbarara, UGA.

Moses MpeirweDepartment of Microbiology, Mbarara University of Science and Technology, Mbarara, UGA.

Godwin TusabeDepartment of National Health Laboratory and Diagnostics Services, Central Public Health Laboratories, Ministry of Health, Kampala, UGA.

Edgar MulogoDepartment of Community Health, Mbarara University of Science and Technology, Mbarara, UGA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe global dissemination of

methodsThis study used whole-genome sequencing to identify the resistome, virulome, mobilome, and multilocus sequence types of selected clinical

resultsMolecular profiling revealed a diverse virulome, with

conclusionThese findings identify a critical genetic variation where high-risk bacteria combine multidrug resistance with an enhanced ability to cause disease. The emergence of these multidrug-resistant bacteria highlights an urgent need for genomic tracking in clinical settings to monitor and prevent their spread.

Indexed as

eskapee pathogenshigh-risk clonesmobile genetic elements (mges)multi locus sequencingresistomevirulome

Identifiers

PMID42186619

DOI10.7759/cureus.107624

PMCPMC13198692

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.